Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 11, 2021 at 10:46 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 120.952 million compared to TWD 82.946 million a year ago. Operating income was TWD 17.277 million compared to TWD 3.406 million a year ago. Net income was TWD 10.403 million compared to TWD 2,000 a year ago. Basic earnings per share was TWD 0.26. Diluted earnings per share was TWD 0.24. For the half year, sales was TWD 234.817 million compared to TWD 171.675 million a year ago. Operating income was TWD 33.142 million compared to operating loss of TWD 1.647 million a year ago. Net income was TWD 21.738 million compared to net loss of TWD 5.693 million a year ago. Basic earnings per share was TWD 0.56 compared to basic loss per share of TWD 0.2 a year ago. Diluted earnings per share was TWD 0.53 compared to diluted loss per share of TWD 0.2 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.